TOP
お知らせ
プレスリリース
企業案内
製品
導入事例
COVID-19 Archive
マンガシリーズ
研究開発
イベント情報
採用情報
お問い合わせ
English
COVID-19 Archive
COVID-19 Archive|ワクチン
絞り込み
期間:
すべての期間
2021
2020
キーワード:
#すべて
#ウイルス学・疫学
#リスク因子・重症化リスク因子
#ワクチン
#基礎研究
#小児・妊婦
#感染伝播・予防策
#検査・診断
#治療薬・治療法
#病態
#臨床症状
#臨床研究
2021.10.19
Waning Immune Humoral Response to BNT162b2 Covid-19 Vaccine over 6 Months (NEJM 2021.10.6)
2021.10.06
Spontaneous Abortion Following COVID-19 Vaccination During Pregnancy (JAMA 2021.9.8)
2021.09.02
Resurgence of SARS-CoV-2 Infection in a Highly Vaccinated Health System Workforce (NEJM 2021.9.1)
2021.08.31
Comparison of SARS-CoV-2 Antibody Response Following Vaccination With BNT162b2 and mRNA-1273(JAMA 2021.8.30)
2021.07.05
Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2 (Nature 2021.6.30)
2021.06.11
Adjunct Immune Globulin for Vaccine-Induced Thrombotic Thrombocytopenia (NEJM 2021.6.9)
2021.05.13
BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants (NEJM 2021.5.12)
2021.05.11
Association Between Vaccination With BNT162b2 and Incidence of Symptomatic and Asymptomatic SARS-CoV-2 Infections Among Health Care Workers (JAMA 2021.5.6)
2021.05.10
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021 (JAMA 2021.4.30)
2021.04.26
Acute Allergic Reactions to mRNA COVID-19 Vaccines (JAMA 2021.3.8)
2021.04.15
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination (NEJM 2021.4.9)
2021.04.15
SARS-CoV-2-Specific Antibodies in Breast Milk After COVID-19 Vaccination of Breastfeeding Women (JAMA 2021.4.12)
2021.04.12
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination (NEJM 2021.4.9)
2021.04.06
SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera (Cell 2021.3.20)
2021.03.16
Covid-19 Vaccine Resource Center(NEJM 2021.4.2)②
2021.03.16
Covid-19 Vaccine Resource Center (NEJM 2021.4.2)①
2021.03.05
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2 (JAMA 2021.3.3)
2021.03.02
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting (NEJM 2021.2.24)
2021.03.02
The Johnson & Johnson Vaccine for COVID-19 (JAMA 2021.3.1)
2021.02.24
How soon will COVID-19 vaccines return life to normal? (Science 2021.2.16)
1
2